Ge Longhui September 12 丨 Smart Pharmaceutical (300149.SZ) held a performance briefing on September 12, 2024 to discuss “the company's AI pharmaceutical-related situation and plans?” The company said that it has applied AI technology such as AlphaFold to drug research and development businesses such as drug design and antibody engineering, and continues to pay attention to the application of artificial intelligence technology in new fields of pharmaceutical research and development. As a CRO company with more than 20 years of experience in pharmaceutical services, the company has accumulated rich experience and has innate application advantages in AI pharmaceuticals. The company is actively exploring new technologies in CRO+AI research and development to improve the company's R&D efficiency and customer service response speed.
睿智医药(300149.SZ)：已将Alphafold等AI技术应用于药物设计、抗体工程等药物研发业务中
Chempartner Pharmatech (300149.SZ): has applied AI technologies such as Alphafold to drug design, antibody engineering, and other pharmaceutical research and development businesses.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.